Pharmacokinetic/Pharmacodynamic Analysis the Probability of Target Attainment of Posaconazole against Mucorales Species in Patients with Mucormycosis
Ying Wang, Jingyi Zhao, Yinhui Yao, Junhui Hu, Jiuli Hu, Xu Xiao, Yanwu Zhao

Pharmacol. Pharm. Vol.11 No.5, May 15, 2020
DOI: 10.4236/pp.2020.115007

The Japanese Community Pharmacists’ Perceptions of the Health Support Pharmacy System
Noritake Hirota, Noboru Okamura

Pharmacol. Pharm. Vol.11 No.4, April 30, 2020
DOI: 10.4236/pp.2020.114006

Transdermal Formulation Development and Topical Administration of Atenolol to Cats
Sumeia M. Mohamed, John Mark Christensen, Nicole LeBlanc

Pharmacol. Pharm. Vol.11 No.3, March 31, 2020
DOI: 10.4236/pp.2020.113005

Optimization of Dalbavancin in Patients with Hepatic or Renal Impairment
Ying Wang, Jingyi Zhao, Yinhui Yao, Junhui Hu, Jiuli Hu, Xu Xiao, Yanwu Zhao

Pharmacol. Pharm. Vol.11 No.2, February 28, 2020
DOI: 10.4236/pp.2020.112004

Analysis of Pharmacokinetic/Pharmacodynamic Parameters and Dosage Regimen of Posaconazole against Candida spp. and Aspergillus spp. Using Monte Carlo Simulation
Ying Wang, Jingyi Zhao, Junhui Hu, Xinhong Zhao, Yinhui Yao

Pharmacol. Pharm. Vol.11 No.1, January 17, 2020
DOI: 10.4236/pp.2020.111003